C Lascols
Overview
Explore the profile of C Lascols including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gargis A, McLaughlin H, Conley A, Lascols C, Michel P, Gee J, et al.
mSystems
. 2018 Dec;
3(6).
PMID: 30574557
Penicillin (PEN) is a low-cost option for anthrax treatment, but naturally occurring resistance has been reported. β-Lactamase expression (, ) in Bacillus anthracis is regulated by a sigma factor (SigP)...
2.
Hackel M, Lascols C, Bouchillon S, Hilton B, Morgenstern D, Purdy J
Vaccine
. 2013 Aug;
31(42):4881-7.
PMID: 23928466
Streptococcus pneumoniae remains a leading cause of disease in children and adults. Serotypes differ in invasiveness, virulence, and antibiotic resistance; therefore, serotype surveillance is necessary to monitor the burden of...
3.
Hawser S, Bouchillon S, Lascols C, Hackel M, Hoban D, Badal R, et al.
Clin Microbiol Infect
. 2011 Jun;
18(3):253-9.
PMID: 21635662
A total of 3160 clinical isolates of Escherichia coli from intra-abdominal infections were collected during 2008-2009 from 13 European countries. The frequency of extended-spectrum β-lactamase (ESBL)-producing isolates in Europe was...
4.
Lascols C, Legrand P, Merens A, Leclercq R, Muller-Serieys C, Drugeon H, et al.
Int J Antimicrob Agents
. 2011 Feb;
37(3):235-9.
PMID: 21295447
The aims of this study were to determine the in vitro activity profile of ceftobiprole, a pyrrolidinone cephalosporin, against a large number of bacterial pathogens and to propose zone diameter...
5.
Lascols C, Legrand P, Merens A, Leclercq R, Armand-Lefevre L, Drugeon H, et al.
Eur J Clin Microbiol Infect Dis
. 2010 Nov;
30(4):475-82.
PMID: 21088861
The aims of the study were to determine the in vitro activity of doripenem, a new carbapenem, against a large number of bacterial pathogens and to propose zone diameter breakpoints...
6.
Soussy C, Lascols C, Dib-Smahi C
Med Mal Infect
. 2007 Oct;
37(11):773-5.
PMID: 17936533
The objective of this study was to assess the in vitro activity of levofloxacin compared to other antibiotics against Escherichia coli strains isolated from female patients with acute pyelonephritis in...
7.
Cambau E, Lascols C, Sougakoff W, Bebear C, Bonnet R, Cavallo J, et al.
Clin Microbiol Infect
. 2006 Sep;
12(10):1013-20.
PMID: 16961639
Bacteria harbouring the novel qnrA plasmid-mediated mechanism of quinolone resistance have been described in different countries, but the frequency of their occurrence has not been investigated. In total, 1,468 clinical...
8.
Honore S, Lascols C, Malin D, Targaouchi R, Cattoir V, Legrand P, et al.
Pathol Biol (Paris)
. 2006 Feb;
54(5):270-9.
PMID: 16473479
Aim Of The Study: To assess the prevalence of the novel plasmid-mediated resistance to quinolones in enterobacteria isolated in our hospital. Materials And Methods: We have screened 737 enterobacterial strains...
9.
Muller-Serieys C, Drugeon H, Etienne J, Lascols C, Leclercq R, Nguyen J, et al.
Clin Microbiol Infect
. 2004 Mar;
10(3):242-6.
PMID: 15008946
In total, 844 strains of Gram-positive cocci were collected from six university hospitals in France between September 1999 and January 2000. MICs of linezolid were determined: (i) for all strains...
10.
Bachoual R, Ouabdesselam S, Mory F, Lascols C, Soussy C, Tankovic J
Microb Drug Resist
. 2002 Jan;
7(3):257-61.
PMID: 11759087
We looked for the presence of gyrA mutations in seven fluoroquinolone-resistant French clinical isolates of Campylobacter jejuni and Campylobacter coli. Three of the five isolates of C. jejuni and the...